-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HP1XfaIlkKLT17dY1dDxvyN35PoOSkKhqR/D7kxm5u8maKgQK3oJrs0yuOVPw2z0 pnulnhGYIpQHPMmgc5umSQ== 0001144204-10-066557.txt : 20101215 0001144204-10-066557.hdr.sgml : 20101215 20101215124532 ACCESSION NUMBER: 0001144204-10-066557 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101214 FILED AS OF DATE: 20101215 DATE AS OF CHANGE: 20101215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KELLS BUILDING STREET 2: 621 SHADY RETREAT RD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: PO BOX 1349 STREET 2: LANDMARK BLDG, 10 S CLINTON ST CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CUDDIHY ROBERT V JR CENTRAL INDEX KEY: 0001142043 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 101252829 MAIL ADDRESS: STREET 1: PARKER DURYEE ET AL STREET 2: 529 FIFTH AVE 8TH FL CITY: NEW YORK STATE: NY ZIP: 10017 4 1 v205617_ex.xml X0303 4 2010-12-14 0 0000868278 ProPhase Labs, Inc. PRPH 0001142043 CUDDIHY ROBERT V JR 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 0 1 0 0 Chief Operating Officer Common Stock, par value $0.0005 2010-12-14 4 A 0 9811 0 A 36111 D Option (right to buy) 1.00 2010-12-15 4 A 0 200000 0 A 2017-12-15 Common Stock 200000 200000 D These restricted shares of common stock were issued pursuant to the terms of Mr. Cuddihy's employment agreement dated August 19, 2009. The transaction reported in the row involves a grant by the Issuer to the Reporting Person of options to purchase the Issurer's common stock that will vest in four annual installments beginning December 15, 2011, as detailed in a stock option award agreement by and between the Issurer and the Reporting Person, dated as of December 15, 2010. /s/ Robert V. Cuddihy, Jr. 2010-12-15 -----END PRIVACY-ENHANCED MESSAGE-----